Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating activities:
Net loss	$ (14,185,306)	$ (11,799,379)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	103,168	97,915
Stock-based compensation expense	736,119	515,762
Change in deferred income taxes	(1,675,381)	332,885
Changes in operating assets and liabilities:
Prepaid expenses, deposits and other assets	518,169	426,774
Accounts payable, accrued expenses and other liabilities	950,602	567,668
Net cash used in operating activities	(13,552,629)	(9,858,375)
Cash flows provided by financing activities:
Proceeds from the sale of common stock	10,827,100
Proceeds from the sale of common stock, pre-funded warrants and warrants		12,318,956
Proceeds from the exercise of common stock warrants and pre-funded warrants	8,046,103	3,888,425
Payment of offering costs	(982,328)	(162,829)
Net cash provided by financing activities	17,890,875	16,044,552
Net increase in cash and cash equivalents	4,338,247	6,186,177
Cash and cash equivalents at beginning of year	14,177,349	7,991,172
Cash and cash equivalents at end of year	18,515,595	14,177,349
Supplemental disclosure of non-cash investing and financing activities:
Offering costs in accounts payable and accrued expenses		238,232
Operating lease right of use asset and liability		$ 334,205